Parenteral nutrition support for patients with pancreatic cancer. Results of a phase II study.

ABSTRACT:

Background

Cachexia is a common problem in patients (pts) suffering from upper gastrointestinal cancer. In addition, most of these patients suffer from malabsorption and stenosis of the gastrointestinal tract due to their illness. Various methods of supplementary nutrition (enteral, parenteral) are practised. In patients with advanced pancreatic cancer (APC), phase angle, determined by bio-electrical impedance analysis (BIA), seems to be a survival predictor. The positive influence of BIA determinate predictors by additional nutrition is currently under discussion.

Methods

To examine the impact of additional parenteral nutrition (APN) we assessed outpatients suffering from APC and progressive cachexia. The assessment based on the BIA method. Assessment parameters were phase

SUBMITTER: Pelzer U 

PROVIDER: S-EPMC2841666 | biostudies-literature | 2010 Mar

REPOSITORIES: biostudies-literature